The Patent Finder

Signum Dermalogix, Inc.

11 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
5
Ending by 2030
Nov 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 11, 2026
    The maintenance fee for Isoprenyl compounds and methods thereof (US 10,314,802) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
  • 1 fee due Apr 30, 2027
    The maintenance fee for Compounds and methods of use (US 11,802,107) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,461,204Cysteinyl compounds, compositions and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,744,147Isoprenyl compounds and methods thereof
In force (reinstated)
 · From the USPTO record
In force (reinstated)From the USPTO record
US 10,314,802Isoprenyl compounds and methods thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,117,904Use of anti-bacterial agents for the treatment of epithelial-related conditions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,376,383Isoprenyl compounds
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,372,884Isoprenyl compounds and methods thereof
In force (reinstated)
 · From the USPTO record
In force (reinstated)From the USPTO record
US 9,415,026Use of anti-bacterial agents for the treatment of epithelial-related conditions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,912,812Methods for preparing botanical extracts
In force (reinstated)
 · From the USPTO record
In force (reinstated)From the USPTO record
US 10,975,023Compounds and methods of use
In force (reinstated)
 · From the USPTO record
In force (reinstated)From the USPTO record
US 11,518,738Compounds and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited